DuPont Reports Q2 2026 Results

DuPont announced its financial results for the second quarter ended June 30, 2026, and raised financial guidance for the full year 2026.

“We delivered another strong quarter, exceeding our financial guidance and demonstrating our focus on consistent execution,” said Lori Koch, DuPont Chief Executive Officer. “Mid-single-digit organic growth, strong margin expansion, coupled with robust adjusted EPS growth and free cash flow generation, underscore the strength of our market-leading businesses and reflect disciplined execution of our strategic priorities, supported by our ongoing focus on excellence and productivity. We are delivering on our commitments, creating value for all of our key stakeholders and further strengthening the foundation for sustainable, long-term profitable growth.”

Overall, net sales were up 4% on a 4% increase in organic sales. There was a 4% organic sales growth in Healthcare & Water Technologies; 3% organic sales growth in Diversified Industrials.

In Healthcare & Water Technologies, net sales increased 5% on organic sales growth of 4% and a currency benefit of 1%. Healthcare Technologies sales up mid-single digits on an organic basis on broad-based growth led by personal protection and biopharma. Water Technologies sales up low-single digits on an organic basis on continued strength in industrial water and semiconductor markets, partially offset by weakness in the Middle East. 

“Our strong execution and market-driven growth continue to translate into higher earnings and free cash flow generation. As a result of our second quarter outperformance, we are again raising the midpoint of our full-year 2026 operating EBITDA guidance to approximately $1.76 billion and adjusted EPS guidance to $7.24 per share, while increasing our expectation for organic sales growth to slightly above 4%,” said Antonella Franzen, DuPont Chief Financial Officer. With continued strength across healthcare, industrial water, and aerospace end markets, we expect mid- single digit organic sales growth in the second half and remain focused on driving profitable growth and value creation for shareholders.”